Virtual care has its gaps - it’s time we talked about it
For this piece, we wanted to get a deeper industry perspective. So we teamed up with Omada Health CEO Sean Duffy. If you haven’t heard of Omada, it’s one of the OG digital health companies that started out in preventing diabetes and now works across diabetes, hypertension and more. So this analysis represents both of our views.
As an industry, we all talk a lot about virtual-first care. But let’s get real. Telemedicine and remote care have limits. There are times when it works extremely well. And there are times when the patient needs to be seen in person.
We all know that to be true on a deeper level. And yet, we wondered if there would be a way to actually quantify that. How much of our care services could be administered in a virtual setting and what type of treatment needs to stay brick and mortar? And how will that ratio change in the future - and why? As we move from hype to balance, we think that the real work lies ahead. Both ambulatory care managers and new digital entrants alike need to think through the right balance between virtual and in-person.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
Is It Finally the Moment for Alternative Plan Design?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
Privacy AI and the Future of HIPAA
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing privacy, access,